NCT01762046View on ClinicalTrials.gov

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

1,033

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Glipizide

DRUG

Metformin

OTHER

Oral Glucose Tolerance Test

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02116

Brigham and Women's Hospital, Boston

Joslin Diabetes Center, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Joslin Diabetes Center

OTHER

collaborator

Broad Institute of MIT and Harvard

OTHER

lead

Massachusetts General Hospital

OTHER